Literature DB >> 35362859

Dose-Dependent Effect of Supervised Aerobic Exercise on HbA1c in Patients with Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials.

Ahmad Jayedi1,2, Alireza Emadi3, Sakineh Shab-Bidar4.   

Abstract

BACKGROUND: Previous meta-analyses indicated that aerobic exercise can improve glycemic control. However, the optimum dose of exercise is still being discussed.
OBJECTIVE: The aim of this study was to examine the dose-dependent effect of supervised aerobic training (SAT) on glycated hemoglobin (HbA1c).
METHODS: We searched PubMed, Scopus, and Web of Science to May 2021 for randomized trials with an intervention period of 12 weeks or longer evaluating the effect of SAT on HbA1c in adults with type 2 diabetes mellitus. Secondary outcomes included quality of life, change in hypoglycemic medications, and adverse events. A random-effects dose-response meta-analysis was conducted.
RESULTS: The analysis of 26 trials with 1253 participants indicated that each 30-min/week SAT reduced HbA1c by - 0.22 percentage point (95% CI - 0.29 to - 0.15; GRADE = strong). Levels of HbA1c decreased proportionally with the increase in the duration of moderate to vigorous-intensity SAT to 100 min/week (mean difference100 min/week: - 0.96 percentage point, 95% CI - 1.25 to - 0.67), with flattening of the curve at higher duration. Aerobic exercise decreased antidiabetic medications by 13 per 100 patients (risk difference 0.13, 95% CI 0.02-0.23; 7 trials, n = 375; GRADE = moderate), and increased hypoglycemic reactions by 10 per 100 patients (risk difference: 0.10, 95% CI 0.03-0.17; 4 trials, n = 263; GRADE = low) and adverse events by 4 per 100 patients (risk difference: 0.04, 95% CI - 0.02 to 0.11; 2 trials, n = 236; GRADE = low). Limited evidence is available for quality of life.
CONCLUSIONS: Every 30 min/week of moderate to vigorous aerobic exercise can exert a significant effect on HbA1c, with the highest effect observed from 100 min/week and above. However, exercise durations above 100 min/week seem ineffective for further reductions. PROTOCOL REGISTRATION: PROSPERO (CRD42021257251).
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35362859     DOI: 10.1007/s40279-022-01673-4

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.928


  43 in total

1.  Imputing missing standard deviations in meta-analyses can provide accurate results.

Authors:  Toshi A Furukawa; Corrado Barbui; Andrea Cipriani; Paolo Brambilla; Norio Watanabe
Journal:  J Clin Epidemiol       Date:  2006-01       Impact factor: 6.437

Review 2.  Position statement on physical activity and exercise intensity terminology.

Authors:  Kevin Norton; Lynda Norton; Daryl Sadgrove
Journal:  J Sci Med Sport       Date:  2009-12-10       Impact factor: 4.319

3.  Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus.

Authors:  E S Kilpatrick
Journal:  J Clin Pathol       Date:  2008-09       Impact factor: 3.411

Review 4.  Global trends in diabetes complications: a review of current evidence.

Authors:  Jessica L Harding; Meda E Pavkov; Dianna J Magliano; Jonathan E Shaw; Edward W Gregg
Journal:  Diabetologia       Date:  2018-08-31       Impact factor: 10.122

Review 5.  Quality of life assessment in obesity: physical, psychological, and social function.

Authors:  M B Sullivan; L G Sullivan; J G Kral
Journal:  Gastroenterol Clin North Am       Date:  1987-09       Impact factor: 3.806

6.  The Cost of Diabetes Care-An Elephant in the Room.

Authors:  Matthew C Riddle; William H Herman
Journal:  Diabetes Care       Date:  2018-05       Impact factor: 19.112

Review 7.  Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis.

Authors:  Daniel Umpierre; Paula A B Ribeiro; Caroline K Kramer; Cristiane B Leitão; Alessandra T N Zucatti; Mirela J Azevedo; Jorge L Gross; Jorge P Ribeiro; Beatriz D Schaan
Journal:  JAMA       Date:  2011-05-04       Impact factor: 56.272

8.  Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002.

Authors:  Patrick W Sullivan; Elaine H Morrato; Vahram Ghushchyan; Holly R Wyatt; James O Hill
Journal:  Diabetes Care       Date:  2005-07       Impact factor: 19.112

9.  Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!

Authors:  Irl B Hirsch
Journal:  Diabetes Care       Date:  2015-08       Impact factor: 19.112

10.  Global estimates of the prevalence of diabetes for 2010 and 2030.

Authors:  J E Shaw; R A Sicree; P Z Zimmet
Journal:  Diabetes Res Clin Pract       Date:  2009-11-06       Impact factor: 5.602

View more
  2 in total

Review 1.  Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; Vanita R Aroda; Billy S Collins; Robert A Gabbay; Jennifer Green; Nisa M Maruthur; Sylvia E Rosas; Stefano Del Prato; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Tsvetalina Tankova; Apostolos Tsapas; John B Buse
Journal:  Diabetologia       Date:  2022-09-24       Impact factor: 10.460

Review 2.  Does Aerobic plus Machine-Assisted Resistance Training Improve Vascular Function in Type 2 Diabetes? A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Trial Sequential Analysis.

Authors:  Xianshan Guo; Shizhe Guo; Hongmei Zhang; Zhen Li
Journal:  J Clin Med       Date:  2022-07-22       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.